Dali Pharmaceutical Co (SHSE:603963) FCF Margin % : -41.57% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Dali Pharmaceutical Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dali Pharmaceutical Co's Free Cash Flow for the three months ended in Mar. 2024 was ¥-6.37 Mil. Dali Pharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥15.32 Mil. Therefore, Dali Pharmaceutical Co's FCF Margin % for the quarter that ended in Mar. 2024 was -41.57%.

As of today, Dali Pharmaceutical Co's current FCF Yield % is -3.46%.

The historical rank and industry rank for Dali Pharmaceutical Co's FCF Margin % or its related term are showing as below:

SHSE:603963' s FCF Margin % Range Over the Past 10 Years
Min: -49.51 Med: -4.58 Max: 40.77
Current: -49.51

During the past 12 years, the highest FCF Margin % of Dali Pharmaceutical Co was 40.77%. The lowest was -49.51%. And the median was -4.58%.

SHSE:603963's FCF Margin % is ranked worse than
85.13% of 1029 companies
in the Drug Manufacturers industry
Industry Median: 0.05 vs SHSE:603963: -49.51

Dali Pharmaceutical Co FCF Margin % Historical Data

The historical data trend for Dali Pharmaceutical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dali Pharmaceutical Co FCF Margin % Chart

Dali Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-4.94

-14.12

-7.98

-25.09

-38.62

Dali Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-20.45	-75.44	-101.66	34.86	-41.57

Competitive Comparison of Dali Pharmaceutical Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Dali Pharmaceutical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dali Pharmaceutical Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dali Pharmaceutical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Dali Pharmaceutical Co's FCF Margin % falls into.

Dali Pharmaceutical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Dali Pharmaceutical Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-33.706	/	87.27
	=	-38.62 %

Dali Pharmaceutical Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-6.369	/	15.32
	=	-41.57 %

Dali Pharmaceutical Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Dali Pharmaceutical Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dali Pharmaceutical Co (SHSE:603963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dali Pharmaceutical Co Ltd (SHSE:603963) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

No. 118, Huancheng West Road, Yunnan Province, Xiaguan Town, Dali, CHN, 671000

Website

http://www.daliyaoye.cn

Dali Pharmaceutical Co Ltd operates in the pharmaceutical manufacturing industry. It is engaged in the research and development and production of Chinese and Western medicine injection products. The company's main products are Zhongjing Brand Xingnaojing Injection, Shenmai Injection, Astragalus Injection, Brighten A Injection and Cell Diphosphocholine injection.

Executives

Wu Pei Rong	senior management
Yang Jun Xiang	Directors, senior managers
Yang Jun Wei	Director

Dali Pharmaceutical Co (SHSE:603963) Headlines

No Headlines